COVID-19 pandemic and autoimmune bullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation.
作者信息
Kasperkiewicz M, Yale M, Strong R, Zillikens D, Woodley D T, Recke A
机构信息
Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
International Pemphigus and Pemphigoid Foundation, Sacramento, CA, USA.
出版信息
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e418-e421. doi: 10.1111/jdv.17228. Epub 2021 Mar 29.
Abstract
摘要
相似文献
1
COVID-19 pandemic and autoimmune bullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation.2019冠状病毒病大流行与自身免疫性大疱性疾病：国际天疱疮和类天疱疮基金会的横断面研究
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e418-e421. doi: 10.1111/jdv.17228. Epub 2021 Mar 29.
2
Role of the International Pemphigus and Pemphigoid Foundation during the COVID-19 pandemic.
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):e664-e665. doi: 10.1111/jdv.18180. Epub 2022 Apr 30.
3
COVID-19 and autoimmune bullous diseases: Lessons learned.COVID-19 与自身免疫性大疱性疾病：经验教训。
Autoimmun Rev. 2023 Apr;22(4):103286. doi: 10.1016/j.autrev.2023.103286. Epub 2023 Feb 2.
4
The impact of COVID-19 pandemic on the number of first diagnosis and follow-up visits of patients affected by pemphigus, bullous pemphigoid, scleroderma, psoriasis and vitiligo: A single-centre experience.
J Eur Acad Dermatol Venereol. 2024 Jun;38(6):e453-e455. doi: 10.1111/jdv.19885. Epub 2024 Feb 24.
5
Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.两种自身免疫性大疱性疾病（天疱疮和大疱性类天疱疮）流行病学的地域差异。
Arch Dermatol Res. 2015 May;307(4):291-8. doi: 10.1007/s00403-014-1531-1. Epub 2015 Jan 15.
6
Evaluation of the Status of Patients with Autoimmune Bullous Diseases (Pemphigus and Bullous Pemphigoids) in Dermatology Clinics of Mashhad University of Medical Sciences During the COVID-19 Pandemic Using Telemedicine.在新冠疫情期间利用远程医疗对马什哈德医科大学皮肤科诊所自身免疫性大疱性疾病（天疱疮和类天疱疮）患者状况的评估
Telemed J E Health. 2024 Jun;30(6):e1742-e1746. doi: 10.1089/tmj.2023.0395. Epub 2024 Feb 27.
7
Severe acute respiratory syndrome coronavirus 2 infection in patients with autoimmune bullous diseases in China.中国自身免疫性大疱性疾病患者中严重急性呼吸综合征冠状病毒 2 感染。
J Dermatol. 2023 Nov;50(11):1433-1441. doi: 10.1111/1346-8138.16900. Epub 2023 Jul 27.
8
Associations of pemphigus or pemphigoid with autoimmune disorders in US adult inpatients.美国成年住院患者天疱疮或类天疱疮与自身免疫性疾病的关联。
J Am Acad Dermatol. 2020 Mar;82(3):586-595. doi: 10.1016/j.jaad.2019.07.029. Epub 2019 Jul 15.
9
The incidence of internal malignancies in autoimmune blistering diseases: pemphigus and bullous pemphigoid in Japan.日本自身免疫性水疱病（天疱疮和大疱性类天疱疮）中内脏恶性肿瘤的发病率。
Dermatology. 1994;189 Suppl 1:82-4. doi: 10.1159/000246937.
10
Autoimmune bullous disorder flares following severe acute respiratory syndrome coronavirus 2 vaccination: a case series.自身免疫性大疱性疾病在严重急性呼吸综合征冠状病毒 2 疫苗接种后发作：病例系列。
J Med Case Rep. 2023 Sep 26;17(1):408. doi: 10.1186/s13256-023-04146-y.
引用本文的文献
1
Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update.大疱性类天疱疮治疗的进展：全面的药物研发管线更新。
Am J Clin Dermatol. 2024 Mar;25(2):195-212. doi: 10.1007/s40257-023-00832-1. Epub 2023 Dec 29.
2
The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets.大疱性类天疱疮的细胞因子环境：当前及新的治疗靶点
Front Med (Lausanne). 2023 Feb 6;10:1128154. doi: 10.3389/fmed.2023.1128154. eCollection 2023.
3
Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine.新冠疫情期间的自身免疫性大疱性疾病：2022年利妥昔单抗与疫苗最新进展
Front Med (Lausanne). 2023 Jan 19;10:1112823. doi: 10.3389/fmed.2023.1112823. eCollection 2023.
4
Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study.评论：与新冠疫苗相关的大疱性类天疱疮：一项意大利多中心研究。
Front Med (Lausanne). 2022 Dec 19;9:1096867. doi: 10.3389/fmed.2022.1096867. eCollection 2022.
本文引用的文献
1
Nonadherence to Treatment and Patient-Reported Outcomes of Psoriasis During the COVID-19 Epidemic: A Web-Based Survey.2019年冠状病毒病疫情期间银屑病患者的治疗依从性及患者报告结局：一项基于网络的调查
Patient Prefer Adherence. 2020 Aug 7;14:1403-1409. doi: 10.2147/PPA.S263843. eCollection 2020.
2
COVID-19 outbreak and autoimmune bullous diseases: A systematic review of published cases.2019冠状病毒病疫情与自身免疫性大疱性疾病：已发表病例的系统评价
J Am Acad Dermatol. 2021 Feb;84(2):563-568. doi: 10.1016/j.jaad.2020.08.012. Epub 2020 Aug 8.
3
Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis.COVID-19 大流行期间普通人群中的压力、焦虑和抑郁患病率：系统评价和荟萃分析。
Global Health. 2020 Jul 6;16(1):57. doi: 10.1186/s12992-020-00589-w.
4
Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency.新冠疫情期间痤疮的远程皮肤病学：尽管处于紧急状态，但患者满意度较高。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e662-e663. doi: 10.1111/jdv.16746. Epub 2020 Jun 26.
5
Association of outdoor activity restriction and income loss with patient-reported outcomes of psoriasis during the COVID-19 pandemic: A web-based survey.新冠疫情期间户外活动限制和收入损失与银屑病患者报告结局的关联：一项基于网络的调查
J Am Acad Dermatol. 2020 Aug;83(2):670-672. doi: 10.1016/j.jaad.2020.05.018. Epub 2020 May 11.
6
Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.2019冠状病毒病大流行期间自身免疫性大疱性疾病管理的专家建议。
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e302-e303. doi: 10.1111/jdv.16525. Epub 2020 Jun 4.
7
Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis.使用广泛性焦虑障碍量表-7（GAD-7）和广泛性焦虑障碍量表-2（GAD-2）筛查焦虑症：一项系统评价与诊断性荟萃分析
Gen Hosp Psychiatry. 2016 Mar-Apr;39:24-31. doi: 10.1016/j.genhosppsych.2015.11.005. Epub 2015 Nov 18.
8
Validity of occupational stress assessment using a visual analogue scale.使用视觉模拟量表评估职业压力的有效性。
Occup Med (Lond). 2011 Sep;61(6):434-6. doi: 10.1093/occmed/kqr037. Epub 2011 Apr 19.
9
The Patient Health Questionnaire-2: validity of a two-item depression screener.患者健康问卷-2：一项两项抑郁症筛查工具的效度
Med Care. 2003 Nov;41(11):1284-92. doi: 10.1097/01.MLR.0000093487.78664.3C.
Zotero 插件